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Abstract 
Background: Campylobacter jejuni is considered as a chicken commensal. The gut microbiota and the immune 
status of the host may affect its colonization. Infectious bursal disease virus (IBDV) is an immunosuppressive virus of 
chickens, which allows secondary pathogens to invade or exacerbates their pathogenesis. To investigate the effect 
of IBDV-induced immunosuppression on the pathogenesis of C. jejuni, broiler chickens were inoculated with a very 
virulent (vv) strain of IBDV at 14 days post hatch followed by C. jejuni inoculation at 7 (Experiment A) or 9 (Experiment 
B) days post virus (IBDV) inoculation.
Results: vvIBDV-infection led to a depression in caecal lamina propria B lymphocytes and the anti-C. jejuni-antibody 
response starting at 14 days post C. jejuni inoculation (pbi). The C. jejuni-colonization pattern was comparable 
between mono-inoculated groups of both experiments, but it varied for vvIBDV + C. jejuni co-inoculated groups. In 
Experiment A significant higher numbers of colony forming units (CFU) of C. jejuni were detected in the caecum of co-
inoculated birds compared to C. jejuni-mono-inoculated birds in the early phase after C. jejuni-inoculation. In Experi-
ment B the clearance phase was affected in the co-inoculated group with significantly higher CFU at 21 days pbi 
compared to the mono-inoculated group (P < 0.05). No major differences were seen in numbers local lamina propria 
T lymphocyte populations between C. jejuni-inoculated groups with or without vvIBDV-infection. Interestingly, both 
pathogens affected the microbiota composition. The consequences of these microflora changes for the host have to 
be elucidated further.
Conclusion: Our data suggests that the timing between viral and bacterial infection might affect the outcome of C. 
jejuni colonization differently. Our results confirm previous studies that anti-Campylobacter-antibodies may specifically 
be important for the clearance phase of the bacteria. Therefore, as vvIBDV is widely distributed in the field, it may have 
a significant impact on the colonization and shedding rate of C. jejuni in commercial poultry flocks. Subsequently, suc-
cessful IBDV-control strategies may indirectly also benefit the gut-health of chickens.
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Background
Campylobacter jejuni is the leading cause of bacte-
rial food-borne gastroenteritis in humans in industrial 
countries. Poultry is considered as the main reservoir for 
C. jejuni, with high bacterial loads in the gastrointesti-
nal tract. C. jejuni has been regarded as a commensal for 
chickens [1]. However, recent studies have reported that 
C. jejuni may induce a mild inflammatory response and 
affects the gut morphology in colonized chickens [2, 3]. It 
is therefore suggested that C. jejuni may have a substan-
tial impact on the chicken’s health and welfare [2].
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Different risk factors may affect the colonization pat-
tern of C. jejuni in chickens including strain to strain 
variation, the inoculation dose, host genotype, manage-
ment as well as water and feed composition [3, 4]. Poor 
gut health and compromised immunity are considered to 
negatively influence the chicken’s health [2].
Different pathogens may modify the functionality of 
the immune system [4]. Infectious bursal disease virus 
(IBDV) is one of the most important immunosuppres-
sive viruses affecting the chickens worldwide [5]. Both 
humoral and cell-mediated immune responses (CMI) 
are affected. IBDV-infected birds show systemic as well 
as local depletion of B cells, infiltration of T cell subsets 
in the bursa of Fabricius (BF) and modulation of innate 
immune parameters [5–7]. IBDV infection leads to a 
strong upregulation of proinflammatory mediators and 
cytokines, a so called ‘cytokine storm’, in the acute phase 
and even cause death during this period [6, 7]. Surviving 
chickens may suffer from permanent immunosuppres-
sion when they were infected early in life [5, 8]. Immuno-
suppressed chickens are more susceptible to secondary 
infections, which was experimentally demonstrated after 
IBDV-co-inoculation with Salmonella typhimurium (ST) 
and Escherichia coli [9, 10]. Inoculation of specific-path-
ogen-free (SPF) birds with an IBDV Del-E strain led to an 
increase in ST shedding, and anti-ST immune reactions 
were dramatically impaired in co-infected birds [10]. 
Increased C. jejuni colonization and shedding was dem-
onstrated in chickens co-inoculated with a Del-E strain 
of IBDV and C. jejuni [11]. Another study showed that 
vaccination of chickens with an intermediate IBDV strain 
led to lesion development in the gut and liver when birds 
were also inoculated with C. jejuni in comparison to C. 
jejuni mono-inoculated birds [12]. However, the mecha-
nisms leading to an exacerbation of C. jejuni colonization 
are not fully clear. We speculate that IBDV may modify 
the local C. jejuni colonization pattern. It may compro-
mise the induction of C. jejuni-specific humoral immu-
nity and may have possibly other direct or indirect effects 
on gut immunity [13] and microbiota composition. It was 
suggested that maternal antibodies may protect against 
C. jejuni colonization [14]. However, the role of humoral 
immunity in Campylobacter control has been discussed 
controversially [15]. Recent studies with chemically 
B cell-compromised chickens indicated that humoral 
immunity may be important in the clearance of C. jejuni 
from the small intestine [16].
In the present study, commercial broilers were inocu-
lated with a very virulent (vv) IBDV strain at 2 weeks post 
hatch, when maternally derived anti-IBDV antibodies 
were below the break-through level of the virus. IBDV-
induced suppression of circulation B cells was confirmed 
starting at 3 days post virus (IBDV) inoculation (pvi) in 
both experiments lasting up to 9  days pvi. Subgroups 
of vvIBDV-inoculated and virus-free birds were subse-
quently orally inoculated with C. jejuni at two different 
time points expecting birds to be at different stages of 
IBDV-pathogenesis and induced immunosuppression: 
In experiment (Exp.) A, birds were C. jejuni-inoculated 
at seven and in Exp. B at 9  days pvi. Lesion develop-
ment, replication of pathogens as well as gut associated 
immune parameters and microbiota composition were 
determined.
Methods
Inocula of vvIBDV and C. jejuni
The vvIBDV strain 89163/7.3 was kindly provided by N. 
Eterradossi, AFSSA, Ploufragan, France [17]. vvIBDV 
propagation was described before [17]. A challenge dos-
age of  103 egg infectious dose (EID)50/bird via eye drop 
was used.
The C. jejuni strain Lior 6 was isolated from a chicken 
at the Clinic for Poultry, University of Veterinary Medi-
cine Hannover, Germany [3]. The preparation and quan-
tification of the inoculum was described previously [3]. 
Briefly, the bacteria, which were stored at − 80  °C in 
skim milk, were thawed and incubated for 48 h at 38 °C 
on Charcoal Cefoperazone Deoxycholate Agar (CCDA, 
Oxoid, Basingstoke, England) under microaerobic con-
ditions. After an additional 48  h of incubation, one 
colony of C. jejuni was transferred into three ml Stand-
ard-I-Bouillon (Merck, Darmstadt, Germany) and incu-
bated for another 48  h under microaerobic conditions 
at 38  °C. The inoculation dose in both experiments was 
adjusted to  106 colony forming units (CFU) per chicken 
in 1 ml of sterile PBS and was applied via crop inocula-
tion. The exact bacterial concentration was obtained by 
plating the inocula on CCDA plates in tenfold dilution 
series [3]. After microaerobic incubation at 38 °C for 48 h 
the colonies were counted to calculate the actual CFU/
inoculum [18]. The CFU numbers of the inoculum were 
confirmed to be  106.57 and  106.7 CFU/ml in Exp. A and B, 
respectively.
Cell isolation and flow cytometric analysis of circulating 
Bu1 + lymphocytes
Full blood samples with the addition of EDTA were col-
lected (0.5  ml/bird, n = 10/group) and diluted in the 
same amount of PBS. A gradient centrifugation (Biocoll, 
1.09 g/ml; Biochrom AG, Berlin) was performed for the 
isolation of lymphocytes according to manufacturer’s 
instructions [19]. For one-color staining, 2 × 105 cells/
sample were stained with anti-chicken Bu1 + monoclonal 
antibodies labeled with fluorescein isothiocyanate (FITC) 
at a concentration of 0.05 µg/ml (Southern Biotech, pro-
vided by Biozol, Eching, Germany) on ice for 30 min in 
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the dark. After three washing steps with PBS containing 
1% fetal bovine serum (FBS, Sigma, USA), the cells were 
acquired by the BD FACSCanto II (Becton–Dickinson, 
Heidelberg, Germany). Samples were analyzed with the 
BD FACS DIVA software (Tree Star Inc., OR, USA). Total 
leukocytes were analyzed by forward and side ward scat-
ter analysis, dead cells were excluded by size, a lympho-
cyte gate was set, and the percentage of Bu1 positive B 
cells was determined within this gate.
Histology
Samples of the bursa of Fabricius (BF) and the middle 
region of the caecum were collected, fixed in 4% (w/v) 
phosphate-buffered formalin, embedded in paraffin, 
sectioned (2  µm) and further processed for histological 
evaluation following standard procedures. The histo-
pathological lesions of the BF were determined via light 
microscopy [20]. Data are presented as % follicles, which 
show more than 50% lymphoid cell depletion. Caecum 
lesions including loss of epithelial integrity, edema, infil-
tration of plasma cells as well as heterophils were also 
evaluated [2].
IBDV‑detection by immunohistochemistry
Bursae were collected, fixed in 4% phosphate-buff-
ered formalin, sectioned and processed as previously 
described [18]. Sections of 2 µm were stained using the 
Universal  Vectorstain® Kit (Vector Laboratories, Burl-
ingame, CA, USA). A polyclonal rabbit anti-IBDV serum 
was used for IBDV-antigen detection [6]. The group 
means of the number of IBDV-antigen positive cells per 
field at a magnification of 200× were calculated based 
on the average number of positive cells in 10 randomly 
selected microscopic fields for each bird per group.
Detection of immune cells by immunohistochemistry
The BF and the middle region of the caecum were snap-
frozen in liquid nitrogen, and sections of 4  µm were 
prepared. The following mouse-anti-chicken primary 
unlabeled antibodies were used: anti-CD4 (clone CT-4), 
anti-CD8β (clone EP-42) and anti-Bu1 (21-1A1) all at a 
concentration of 0.05 µg/ml (Southern Biotech, provided 
by Biozol, Eching, Germany). The secondary anti-mouse 
IgG biotinylated antibodies were used subsequently and 
the enzyme-linked ABC complex was visualized by the 
reaction with 3.3′-diaminobenzidine (DAB) chromagen 
substrate and hydrogen peroxide (DAB peroxidase sub-
strate Kit, Vector Laboratories Inc.) [3]. Sections were 
examined by light microscopy. The T-lymphocyte popu-
lations in the BF were evaluated by counting the number 
of stained cells at a magnification of 200× in five ran-
domly selected microscopic fields per bird [6]. The B and 
T lymphocyte populations in the lamina propria (LP) of 
the caecum were counted in three crypts/field of five ran-
domly selected fields for each bird at a magnification of 
200× [3].
Quantification of the C. jejuni load in caecal content 
and reisolation from other organs
Campylobacter jejuni quantification was done accord-
ing to a previous study [18]. From each C. jejuni-inocu-
lated chicken, one whole caecum was collected. Around 
0.5 g content was tenfold serially diluted with phosphate 
buffered saline (PBS). 100 µl of the diluted samples were 
spread on CCDA plates in duplicates. In addition 1 g of 
liver was collected from each bird, homogenized with 
3.5 ml distilled PBS and spread on CCDA plates in dupli-
cates. For qualitative C. jejuni reisolation from other 
tissues, swab samples of spleen, ileum and BF were col-
lected and plated directly on CCDA plates. The plates 
were incubated under microaerophilic condition at 38 °C 
for 48 h. The calculation of CFU/g was described previ-
ously [3, 18].
RNA extraction and real‑time quantitative RT‑PCR 
(qRT‑PCR) for the detection of cytokine expression
Total RNA was isolated from the BF using 1  ml 
 Trifast®-GOLD reagent (PeqLab, Biotechnologie GmbH, 
Erlangen, Germany) as previously described [3]. RNA 
quality and concentrations were determined using the 
NanoDrop ND-1000 (PeqLab, Biotechnologie GmbH). 
Probes and primers for the detection of interferon 
(IFN)-γ, interleukin (IL-6), and the IL-8 were described 
before [18, 21]. Real-time quantitative RT-PCR was per-
formed with 20 µl reaction mix using the Qscript™ XLT 
One-Step RT-qPCR ToughMix Kit (Applied Biosys-
tems, AMBio.n, USA). Amplification and analysis was 
done with the Mx3005P™ thermal cycle system and the 
Mx3005P™ Q PCR Software (Stratagene, Agilent Tech-
nologies Company, USA), respectively. The following 
cycle profile was applied: one cycle at 50  °C for 10 min, 
at 95 °C for 1 min, followed by 40 cycles at 95 °C for 10 s 
and 60 °C for 1 min. The data were normalized by using 
the house-keeping gene 28S [18], which was expressed in 
a comparable manner in all samples of infected and non-
infected groups. Results are presented as 40-Ct. All the 
samples were tested in duplicates.
ELISAs for anti‑IBDV and anti‑C. jejuni antibody detection
The commercially available enzyme-linked immuno-
sorbent assay (ELISA) ProFlok IBDV plus antibody test 
kit (Synbiotics Co., Kansas City, Mo.) was used to detect 
circulating anti-IBDV-antibodies [6]. An inhouse biotin-
streptavidin-based ELISA was applied for the detection 
of anti-C. jejuni IgG-type specific antibodies as previ-
ously described [22]. Anti-IBDV-antibody titers are 
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presented as mean titer/group ± standard deviation (SD). 
Average C. jejuni-specific antibodies levels are expressed 
as average OD-values ± SD.
Gut microbiota composition
Following the homogenization of caecal content using 
zirconia silica beads in a MagNALyzer (Roche Diag-
nostics, Basel, Switzerland), DNA was isolated with the 
QIAamp DNA Stool Mini kit according to the manu-
facturer’s instructions (Qiagen, Hilden, Germany). The 
DNA quality and concentration were measured spec-
trophotometrically, and the sequencing of the V3/V4 
variable region of the 16S rRNA genes was performed 
as described before [23]. DNA samples were diluted 
to 5  µg/µl and used as a template with forward primer 
5 ′CGTATCGCCTCCCTCGCGCCATCAG–MID–
GGAGGCAGCAGTRRGGAAT3′, and reverse primer 5′ 
CTATGCGCCTTGCCAGCCCGCTCAG–MID–CTAC-
CRGGGTATCTAATCC3′. The MIDs represent differ-
ent sequences (5, 6, 7, 9 or 12 bp in length) which were 
designed to differentiate samples into groups. The under-
lined sequences were required for amplification of over-
lapping the V3/V4 region of 16S rRNA genes. The KAPA 
Taq HotStart PCR Kit was used for PCR amplification 
and cleanup following manufacturer’s instructions (Kapa 
Biosystems, Boston, MA, USA). The following cycle pro-
file was applied: hot start at 95 °C for 15 min and 95 °C 
for 1 min, followed by 30 repeat cycles consisting of incu-
bation at 94 °C for 40 s, 55 °C for 55 s and 72 °C for 1 min. 
Amplification products were pooled and indexed with 
a Nextera XT index kit and sequenced using the MiSeq 
Reagent Kit v3 and MiSeq apparatus according to the 
manufacturer´s instruction (Illumina). QIIME software 
was used for processing the sequencing data [23]. The 
sequences which are presented were classified by RDP 
Seqmatch with OTUs (operational taxonomic units), and 
the principal coordinate analysis (PCoA) was used for 
data visualization.
Animals and experimental procedure
Two experiments were conducted with four groups 
each: the non-inoculated control (control-group), the 
vvIBDV mono-inoculated (vvIBDV-group) and the 
C. jejuni mono-inoculated group (C. jejuni-group), as 
well as the vvIBDV + C. jejuni co-inoculated group 
(co-inoculation-group).
Animals
One-day-old commercial broiler chicks (Ross 308) were 
purchased from the Hatchery Weser-Ems (BWE), Visbek, 
Rechterfeld, Germany. All broilers were raised in one 
room at the Clinic for Poultry under isolation conditions 
on wood shavings until the age of 14  days. Afterwards, 
birds were randomly assigned to different groups and 
moved to different isolation rooms or Horsfall-Bauer-
type isolators. Birds of all the groups received commercial 
broiler feed and water from the same source throughout 
the experiments, which were provided ad  libitum. The 
chicks did not receive any vaccination. Experiments were 
conducted according to the regulations for animal wel-
fare of Lower Saxony and were approved by the Lower 
Saxony State Office for Customer Protection and Food 
Safety (LAVES: 33.12-42505-04-13/1215).
Experiment A (Exp. A)
Seventy-two one-day-old commercial broiler chicks 
(Ross 308) were used in Exp. A. Serum samples (n = 15) 
were randomly collected at seven and 14 days post hatch 
and anti-IBDV antibodies were determined by ELISA. 
Anti-IBDV ELISA-titers ranged from  log10 of 1.7–3.7 for 
individual birds, which suggests low maternal anti-IBDV 
antibody titers according to the information provided by 
the ELISA kit manufacturer (ProFLOK PLUS-ELISA kit, 
Zoetis, US) allowing early vvIBDV-infection around day 
14 post hatch [24, 25]. At 14 days post hatch broilers were 
distributed randomly into two groups. One group was 
inoculated with  103  EID50/bird of vvIBDV by eye-drop 
route and the other group (control) received only the dil-
uent PBS. At 3, 5 and 7 day pvi, blood samples were col-
lected (n = 8/group). Peripheral blood leukocytes (PBL) 
were isolated and analyzed by flow cytometric analysis 
for the percentage of circulating Bu1-positive B cells. At 
the same time, cloacal swabs were collected to confirm 
that birds were C. jejuni-free. At 7 days pvi, when circu-
lating B cell numbers were significantly decreased in the 
vvIBDV mono-inoculated group compared to the virus-
free birds (P < 0.05), groups were divided into two sub-
groups (18 birds/subgroup) and orally inoculated with 
 106 CFU of C. jejuni or PBS. Clinical signs were moni-
tored daily throughout the experiment. Six birds from 
each group were sacrificed at three, seven and 14 days pbi 
and pathological lesions were determined. BF, liver and 
spleen were collected to determine organ to body weight 
ratios. Serum samples were used for the detection of 
anti-IBDV and C. jejuni antibodies by ELISA. Samples of 
the BF and caecum were taken for immunohistochemi-
cal detection of different immune cell populations as well 
as IBDV-antigen positive cells. Since the BF is the target 
organ for IBDV replication, the BF was also collected 
for the detection of cytokine mRNA expression by qRT-
PCR at three, seven and 14 days pbi. The caecal content 
was evaluated for microbiota composition by Illumina 
sequencing at 7 days pbi.
Page 5 of 14Li et al. Gut Pathog  (2018) 10:13 
Experiment B (Exp. B)
Ninety-six one-day-old broiler chickens were used in 
Exp. B. The experimental setup of Exp. B was compara-
ble to Exp. A with the exception that C. jejuni inoculation 
took place at 9  days pvi. An additional flow cytometric 
analysis of circulating B cells was conducted with blood 
samples in Exp. B. Six birds from each group were sac-
rificed for necropsy not only at three, seven and 14 days 
but also at 21  days post bacteria inoculation, and col-
lected samples were processed as indicated for Exp. A. 
Unlike in Exp. A cytokine mRNA expression levels in the 
BF were only determined at 3 days pbi.
Statistical analysis
One bird was chosen as the unit for analysis. Statisti-
cal analysis was performed with the Statistix version 9.0 
(Analytical software, Thallahassee, FL, USA). CFU of C. 
jejuni and anti-IBDV-IgG-type antibody levels between 
groups were compared by using Two Sample T test or 
Wilcoxon Rank sum T test. The differences in immune 
cell populations and the cytokine expression pattern 
in the BF between multiple groups were analyzed by 
Kruskal–Wallis all pairwise comparison test. The dif-
ferences in immune cell populations in the caecum, the 
anti-IBDV and anti-C. jejuni antibodies between mul-
tiple groups were evaluated by one-way-ANOVA-Tuk-
ey’s HSD test. Graphs were prepared with GraphPad v6 
(Prism, LaJolla, USA). Differences are considered signifi-
cant at P < 0.05.
Results
vvIBDV induced immunosuppression and effects 
of co‑infection on viral pathogenesis
A similar pattern of anti-IBDV-maternally derived anti-
body (MDA) decline was observed in both experiments 
with ELISA-titers ranging from an average of  log10 
3.7 ± 0.1 to 3.2 ± 0.4 in Exp. A and 3.7 ± 0.3 to 3.3 ± 0.3 
in Exp. B at seven and 14  days post hatch, respectively. 
At 14 days post hatch, anti-IBDV-MDA titers were below 
the break-through level of vvIBDV [24]. Birds were ran-
domly divided into two groups: one group was inocu-
lated with vvIBDV and the other was inoculated with 
diluent PBS as control. vvIBDV induced a significant 
reduction in the number of circulating B cells in both 
experiments. Birds were inoculated with C. jejuni at 7 or 
9 days pvi, when the percentage of circulating B cells was 
significantly reduced in comparison to non-inoculated 
groups in both experiments (Additional file 1: Figure S1, 
P < 0.05). At necropsy this was confirmed and vvIBDV 
had led to a significant bursal atrophy in virus-inoculated 
groups compared to the virus-free controls at the vari-
ous necropsy days (data not shown). High IBDV-antigen-
loads (S2 Fig) and severe histological lesions (Additional 
file 2: Table S1) were seen in the BF of all virus-infected 
groups. No significant differences were detected in the 
number of IBDV-antigen-positive cells neither between 
virus-inoculated and vvIBDV + C. jejuni co-inoculated 
groups nor between experiments (Additional file 3: Fig-
ure S2). Co-inoculation with C. jejuni did not significantly 
affect IBDV-lesion development up to 7 days pbi (14 and 
16 days pvi in Exp. A and B, respectively), nor IBDV-anti-
body development (P > 0.05, data not shown). At the final 
day of each experiment, IBDV serum antibody levels in 
both vvIBDV mono-inoculated as well as vvIBDV + C. 
jejuni co-inoculated birds reached  log10 titers of an aver-
age of 3.9 and 3.8 in Exp. A and B, respectively. Starting 
at 21 and 23 days pvi in Exp. A and B, respectively, there 
was a trend of a slower bursal recovery from histologi-
cal lesions of co-inoculated groups compared to vvIBDV 
mono-inoculated ones, which was significant at 30 days 
pvi in Exp. B (Fig. 1).
Effect of vvIBDV inoculation on C. jejuni colonization
All groups were C. jejuni-negative at the day of bacte-
rial inoculation and all the non-C. jejuni-inoculated 
groups remained C. jejuni- free throughout both experi-
ments. To investigate the effect of vvIBDV inoculation 
on the C. jejuni colonization pattern, two different time 
intervals between the inoculation of virus and bacte-
ria were selected. Overall, comparable numbers of C. 
jejuni CFU were detected in mono-inoculated groups 
between experiments with an average of  log10 of 8.0 ± 0.6, 
8.0 ± 0.4, 7.9 ± 0.4 CFU at 3, 7, and 14 days pbi, respec-
tively (Fig. 2). In Exp. A, significantly higher CFU num-
bers were observed in the caecal content of co-inoculated 
birds compared to C. jejuni mono-inoculated ones at 
3 and 7 days pbi (Fig. 2a, P < 0.05). In Exp. B. CFU were 
significantly lower by 5.4 fold in the co-inoculated birds 
at seven days pbi compared to C. jejuni mono-inoculated 
ones (Fig. 2b, P < 0.05). While C. jejuni mono-inoculated 
birds showed a significant bacterial clearance at 21 days 
pbi, with two birds being negative for C. jejuni in cae-
cal content and four birds with CFU of  log10 of 4.3 ± 1.3, 
co-inoculated birds were all still colonized with C. jejuni 
with CFU of a range of  log10 of 5.6 ± 1.6. Reisolation 
attempts of C. jejuni from ileum confirmed clearance of 
C. jejuni, in 50% of mono-inoculated birds compared to 
100% C. jejuni-positive co-inoculated birds at 21 days pbi 
(Additional file 4: Table S2).
vvIBDV-inoculation did not substantially affect the 
dissemination of C. jejuni to different extraintestinal 
organs (Additional file 4: Table S2). Co-inoculated birds 
had a higher percentage of C. jejuni-positive birds (83%) 
in comparison to C. jejuni mono-inoculated birds (33%) 
at 21 days pbi in the bursa of Fabricius (Additional file 4: 
Table S2).
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Fig. 1 Histological evaluation of bursal recovery of chickens after vvIBDV-mono-inoculation and C.jejuni coinoculation (Exp. B as a representative 
experiment). Representative bursa sections of control (a), C. jejuni- (b), vvIBDV- (b), and vvIBDV + C. jejuni coinoculated (d) chickens at 21 days pbi. 
Arrows indicate recovering follicles B. e A summary of bursal recovery in the BF of chickens at different time points (Exp. A and Exp. B are separated 
by a dotted line) Error bar indicates the standard deviation (SD), *indicates significant differences between the two indicated groups at the indicated 
time point (P < 0.05, n = 6/group). pbi post bacterial inoculation; pvi post IBDV (virus) inoculation
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Effect of vvIBDV on C. jejuni induced lesion development
Neither clinical signs such as depression or diarrhea nor 
mortality were observed in any of the groups during both 
experiments. No significant difference in body weight 
development was observed between the four groups dur-
ing Exp. A and B (data not shown, P > 0.05). Histological 
investigations of caecum sections did not reveal signifi-
cant lesions in any of the investigated groups. vvIBDV-
inoculation led in all groups to a slight infiltration of 
heterophils in the lamina propria as well as the submu-
cosal area (data not shown), which was not observed in 
the virus-free groups.
Effect of vvIBDV‑C. jejuni co‑inoculation on T and B 
lymphocytes in the BF and LP of the caecum
Both vvIBDV and C. jejuni influenced the local immune 
response. Consistent with previous studies [26], 
vvIBDV inoculation led to an increase in T lymphocytes 
(CD4 + and CD8ß +), as well as a depletion of B lympho-
cytes in the BF in the vvIBDV mono-inoculated birds 
(data not shown). C. jejuni had no significant effect on 
lymphoid cell populations in the BF (P > 0.05), and in co-
inoculated birds, numbers were comparable to vvIBDV 
mono-inoculated chickens (data not shown).
In the caecum, vvIBDV mono-inoculation led to a 
decrease in the number of LP B lymphocytes (LPL), 
which was significant at 7  days pbi in both experi-
ments (Fig.  3a and b, P < 0.05, T test). vvIBDV also 
induced an increase of CD4+ and CD8ß+ T LPL at 
10–12 pbi compared to the control groups, which neither 
received vvIBDV nor C. jejuni, (Fig.  3c and d). Also C. 
jejuni-mono-inoculated groups showed increased num-
bers of T and also B cells compared to non-inoculated 
controls at some investigated time points as published 
before [3, 18], which was significant for B and CD4+ T 
cells at seven days pbi in both experiments (P < 0.05, T 
test for the comparison of C. jejuni-mono-inoculated 
and control groups), and for CD8+ T cells at 14 days pbi 
in the Exp. B (P < 0.05, T test for the comparison of C. 
jejuni-mono-inoculated and control groups).
In co-inoculated birds an increase in the number of LP 
B lymphocytes was observed at 7 days pbi compared to 
non-inoculated controls, which was comparable to the 
C. jejuni-mono-inoculated group in both experiments 
(Fig.  3a, b, P < 0.05). This was followed by a decrease 
going in line with the vvIBDV-mono-inoculated chick-
ens, but this difference was not significant compared 
to the non-inoculated controls (Fig.  3a, b, P > 0.05). An 
increase in the number of T LPL was observed in the co-
inoculated birds compared to the non-inoculated con-
trols at most investigated time points pbi both in Exp. 
A and B (Fig. 3c–f). Numbers were comparable at most 
time points to C. jejuni mono-inoculated groups (Fig. 3, 
P < 0.05).
Effect of vvIBDV‑C. jejuni co‑inoculation on cytokine 
expression
vvIBDV mono-inoculation significantly affected the 
mRNA expression of IL-8 and IFN-γ in the BF. In Exp. A 
a significant upregulation of IL-8 was detected at 7 days 
pvi compared to the non-inoculated controls (P < 0.05). 
A significant upregulation of IFN-γ was observed in Exp. 
A at all investigated time points in the vvIBDV mono-
inoculated birds in comparison to non-inoculated con-
trols (Fig. 4, P < 0.05), which was confirmed for day 3 pbi 
Fig. 2 Average colony forming units (CFU) of C. jejuni in the caecal content of C. jejuni-mono-inoculated and co-inoculated birds of Exp. A (a) and 
Exp. B (b). pbi post bacterial inoculation; pvi post IBDV (virus) inoculation. C. jejuni = C. jejuni mono-inoculated group, co-inoculation = vvIBDV + C. 
jejuni co-inoculated group. Error bar indicates the standard deviation (SD). *indicates significant difference between two groups at the indicated 
days pbi (*P < 0.05, n = 6/group)
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in Exp. B (the only investigated time point in this experi-
ment, data not shown).
Campylobacter jejuni inoculation led to a significant 
upregulation of IL-6 at 14 days pbi in the BF compared to 
non-inoculated controls (Exp. A, Fig. 4a, P < 0.05), while 
the other two cytokines were not affected.
Co-inoculation led to a significant upregulation of IL-6 
at 7 days pbi compared to non-inoculated controls in Exp. 
A. An upregulation of IL-8 gene expressions in co-inocu-
lated birds was observed at 3 and 7 days pbi compared to 
non-inoculated controls, and a significant upregulation 
of IFN-γ was detected at all the investigated time points 
Fig. 3 Immunohistochemical detection of Bu1+ B (a, b) and CD4+ (c, d) as well as CD8 + (e, f) T cells in the lamina propria of the caecum of 
mono- and co-inoculated birds of Exp. A (a, c, e) and Exp. B (b, d, f) (n = 6/group). pbi post bacterial inoculation; pvi post IBDV (virus) inoculation. 
Error bars indicate the standard deviation (SD). abcletters indicate significant differences between groups within the same experiment at the indi-
cated time points (P < 0.05). control = non-inoculated control, C. jejuni = C. jejuni mono-inoculated group, vvIBDV = vvIBDV mono-inoculated group, 
co-inoculation = vvIBDV + C. jejuni co-inoculated group
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in the co-inoculated birds in comparison to non-inocu-
lated controls (Fig. 4, P < 0.05). There were no differences 
in cytokine expression pattern between co-inoculated 
and vvIBDV mono-inoculated birds at most investigated 
time points (P > 0.05). The changes in cytokine expression 
in co-inoculated birds at 3 days pbi were also confirmed 
in Exp. B (data not shown).
Effect of vvIBDV‑C. jejuni coinoculation on C. 
jejuni‑antibody development
Consistent with previous studies [3, 18] a signifi-
cant upregulation of C. jejuni-specific antibodies was 
observed starting at 14 days pbi in the serum of C. jejuni 
mono-inoculated and co-inoculated birds compared to 
non-C. jejuni-inoculated controls in both experiments 
(P < 0.05), there was a trend that antibody levels were 
lower in the co-inoculated group. At 21 days pbi signifi-
cantly lower levels of IgG C. jejuni-specific antibodies 
were detected in co-inoculated birds in comparison to C. 
jejuni mono-inoculated ones (Fig. 5b, P < 0.05).
Effect of vvIBDV‑C. jejuni co‑inoculation on the gut 
microbiota
UniFrac analysis followed by PCoA using weighted and 
unweighted analysis indicated mono-inoculations had 
some effects on the gut microbiota in both experiments 
at 7  days pbi. vvIBDV mono-inoculated birds showed a 
clear separation from non-inoculated controls (Fig.  6a 
and b). C. jejuni mono-inoculated groups showed a sep-
aration from the non-inoculated controls in Exp. A but 
not in Exp. B. pbi = post bacterial (C. jejuni) inoculation.
The effect of co-inoculation on gut microbiota was dif-
ferent between Exp. A and Exp. B. In Exp. A, gut micro-
biota composition was significantly modified due to the 
co-inoculation, and clearly different to all other three 
groups. In Exp. B, co-inoculated and vvIBDV-inocu-
lated birds grouped together and were clearly separated 
from the C. jejuni mono-inoculated and non-inoculated 
control groups. The abundance of Campylobacter sig-
nificantly increased in the co-inoculated birds (2.76%) 
compared to C. jejuni mono-inoculated ones (2.40%) 
in Exp. A. The opposite was observed for Exp. B (co-
inoculated birds (8.83%), C. jejuni mono-inoculated 
(10.72%)), which confirmed the data of the CFU in the 
caecal content at this time point. In both experiments, 
we observed that C. jejuni inoculation induced a sig-
nificant lower abundance of Lachnospiracea incertae 
sedis and Roseburia in both experiments, and a lower 
abundance of Eubacterium in the caecal content of C. 
Fig. 4 mRNA expression of IL-6 (a), IL-8-homolog (b) and IFN-γ (c) 
in the BF of birds of Exp. A (n = 6/group). The data is presented as 
40-CT normalized to 28S. pbi post bacterial (C. jejuni) inoculation; pvi 
post IBDV (virus) inoculation. Error bars indicate the standard devia-
tion (SD), abcletters indicate significant differences between groups 
within the same experiment at the indicated time points (P < 0.05). 
control = non-inoculated control, C. jejuni = C. jejuni mono-inoculated 
group, vvIBDV = vvIBDV mono-inoculated group, co-inocula-
tion = vvIBDV + C. jejuni co-inoculated group
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jejuni mono-inoculated birds compared to non-inocu-
lated controls, which was significant in Exp. B (Table 1). 
In addition vvIBDV infection led to a slight differ-
ence in the abundance of Faecalibacterium between 
Exp. A and Exp. B compared to control. A significant 
higher abundance of Faecalibacterium was observed in 
vvIBDV-mono-inoculated birds compared to non-inocu-
lated controls in Exp. A, while in Exp. B only a significant 
lower abundance was detected (Table  1, P < 0.05). Co-
inoculated birds showed a significant lower abundance of 
Lachnospiracea incertae sedis in the caecum compared to 
non-inoculated controls in both experiments (Table 1).
Fig. 5 Induction of C. jejuni-specific IgG-type antibodies in serum of mono- and co-inoculated birds of the Exp. A (a) and Exp. B (b). pbi = post C. 
jejuni bacterial inoculation; pvi = post IBDV (virus) inoculation. Error bars indicate the standard deviation (SD), abcletters indicate significant differ-
ences between groups within the same experiment at the indicated time points (P < 0.05). control = non-inoculated control, C. jejuni = C. jejuni 
mono-inoculated group, vvIBDV = vvIBDV mono-inoculated group, co-inoculation = vvIBDV + C. jejuni co-inoculated group. Dotted line shows the 
cut-off level
Fig. 6 Microbiota diversity in the caecal content of birds from the Exp. A (a) (14 days pvi) and Exp. B (b) (16 days pvi) at 7 days pbi. UniFrac analysis 
followed by PCoA indicates variability in the caecal microbiota composition of birds. Control = non-inoculated control, C. jejuni = C. jejuni mono-
inoculated group, vvIBDV = vvIBDV mono-inoculated group, co-inoculation = vvIBDV + C. jejuni co-inoculated group. pbi = post bacterial (C. jejuni) 
inoculation
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Discussion
In this study we investigated the effect of vvIBDV-
induced immunosuppression on C. jejuni coloniza-
tion. Two experiments were conducted using broiler 
chicks from the same genotype with comparable IBDV-
maternally derived antibody levels.Broiler chickens were 
inoculated with vvIBDV at 14 days post hatch. Virus rep-
lication, as indicated by high numbers of IBDV-antigen 
positive cells in the BF, was confirmed [6]. Monitoring of 
circulating B cells showed a significant decrease in rela-
tive B cell numbers from 5  days pvi onwards (P < 0.05) 
compared to the virus-free controls. We also observed 
bursal atrophy with B cell depletion. vvIBDV-antigen-
loads, sero-conversion as well as bursa lesion develop-
ment were comparable between Exp. A and B. These 
results are consistent with previous studies confirm-
ing vvIBDV infection and immunosuppression [5, 7, 8]. 
Although previous studies indicated an effect of IBDV 
on C. jejuni-colonization (Subler et  al. [11]; Stojanov 
et al. [12]), the influence of the time interval between the 
inoculations of the pathogens on the outcome of infec-
tions was not investigated. Co-inoculation experiments 
with various other pathogens in  vitro and in  vivo dem-
onstrated clearly a significant influence of the time inter-
val on the pathogenesis of either infectious agent [27, 28]. 
Two different time points after vvIBDV-inoculation were 
selected for C. jejuni-inoculation. Seven and 9  days pvi 
were chosen, which was after the acute phase of vvIBDV 
infection, when the effects on B cells were expected to 
be most prominent and numbers of B cells were clearly 
depressed but the vvIBDV-induced cytokine storm may 
have waned [5, 20]. It would have been desirable to inves-
tigate both time points of C. jejuni-inoculation within 
one experiment, which was not possible in this experi-
ment due to logistic constrains. But the comparable 
outcome of vvIBDV-infection and the comparable C. 
jejuni colonization rate between three and 14 days pbi in 
mono-inoculated groups in both experiments allows the 
direct comparison of both experiments.
Interestingly, co-inoculation with C. jejuni may delay 
follicular recovery, although the mechanisms behind this 
observation that are not clear.
Two days difference in C. jejuni-inoculation after 
vvIBDV-infection had a significant effect on the outcome 
of C. jejuni colonization. In Exp. A the early phase of C. 
jejuni colonization was clearly impacted by vvIBDV, lead-
ing to 2.8- to 8.1-fold higher CFU in co-inoculated birds 
compared to C. jejuni mono-inoculated ones. In Exp. 
B vvIBDV affected mainly the colonization pattern at 
21 days pbi, which might correlate with the clearance of 
C. jejuni. Co-inoculated birds had significant higher CFU 
with all six birds having a CFU range between  log10 of 3.2 
and 8 in the caecum compared to the mono-inoculated 
group, in which two birds were C. jejuni negative by cul-
ture of caecal content and four had CFU of 4.3 ± 1.7 at 
21 days pbi (P < 0.05). Possibly this effect would also have 
been seen in Exp. A, if the experiment would have been 
extended. Interestingly this significantly higher bacterial 
load in co-inoculated birds at 21 days pbi coincided with 
a reduced C. jejuni-specific antibody response compared 
to the C. jejuni mono-inoculated groups (P < 0.05). Anti-
body levels were significantly lower at 21 days pbi in co-
inoculated birds compared to C. jejuni mono-inoculated 
ones in Exp. B. A trend of a compromised anti-C. jejuni-
antibody response was already visible at 14  days pbi in 
both experiments. These results provide circumstantial 
evidence that C. jejuni-infection may be controlled by 
humoral immunity as suggested before [14]. In Cyclo-
phosphamide-immunocompromised birds the same 
trend was observed that antibodies may play a significant 
Table 1 Analysis of microbiota composition in mono-and co-inoculated groups in comparison to non-inoculated controls 
at 7 days pbi
* Significant differences in the abundance of OTUs, P < 0.05 (2-sample T test)
–: no significant differences (P > 0.05); pbi: post bacterial (C. jejuni) inoculation
Genus Significant differences as indicated by * in the abundance of bacterial genus in
Exp. A Exp. B
C. jejuni vvIBDV Co‑inoculation C. jejuni vvIBDV Co‑inoculation
Campylobacter * – * * – *
Clostridium XlVa * * * * * –
Eubacterium – – * * * *
Faecalibacterium – * – – * –
Lachnospiracea incertae sedis * * * * – *
Lactobacillus * – – * – –
Roseburia * * * – – *
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role in the bacterial clearance phase later after inocula-
tion [16]. Further studies need to be done, to evaluate the 
local C. jejuni-specific IgA-response to confirm the role 
of local humoral immunity in C. jejuni-colonization.
An additional confirmation of vvIBDV-induced B cell 
depletion, and the lack or reduced stimulation of the B 
cell-mediated anti-C. jejuni-response is provided by 
the reduced number of LP B lymphocytes in co-inocu-
lated birds compared to C. jejuni mono-inoculated ones 
(P < 0.05). While C. jejuni mono-inoculation led to an 
upregulation of LP B lymphocytes starting at three days 
pbi in Exp. A, and on days three and seven pbi in Exp. B, 
there was only a detectable B cell upregulation in the co-
inoculated groups at seven days pbi in both experiments. 
At 14 days pbi local B cell numbers were reduced in co-
inoculated groups compared to most other groups.
This effect of vvIBDV on the C. jejuni-specific antibody 
response is interesting, as this effect was most prominent 
at 21–23  days pvi, when virus clearance in the BF was 
very much advanced and beginning bursal recovery was 
observed in both vvIBDV-inoculated groups. This clearly 
shows that B cell immunosuppression lasts beyond the 
acute phase and the effects on secondary infections may 
be detectable over 14 days post vvIBDV-infection. Previ-
ous studies demonstrated that bursal recovery with two 
different types of follicle structures starts 5  weeks post 
IBDV infection [8, 29, 30]. The larger follicles are corre-
lated with partial recovery of the antibody responsive-
ness, while the smaller follicles appear unable to produce 
antigen-responsive B cells [29, 30], which suggested that 
immunosuppression was maintained. In Exp. A other 
immunosuppressive or immunomodulatory effects 
beside the depression of the humoral immunity may have 
additionally affected C. jejuni colonization as already 
early bacterial replication was exacerbated in co-inocu-
lated groups at 3 and 7 days pbi. It was shown in a vari-
ety of other studies, that during the early phase of IBDV 
infection not only the humoral immunity may be com-
promised in IBDV-infected birds but also macrophage 
activity, and indirectly the cell-mediated immunity [5, 7].
There was no information available regarding the effect 
of vvIBDV infection on the gut microbiota in chickens. 
It may be speculated that due to its immunosuppressive 
effects on the gut-associated immune system [13] IBDV 
may indirectly modulate the composition of the microflora. 
Effects like that were previously seen in chickens infected 
with Marek’s disease virus (MDV) [31], and also in humans 
after infection with human immunodeficiency virus (HIV) 
[32]. Interestingly, vvIBDV modified the gut-microbiota 
composition in both experiments compared to control 
birds as indicated by the PCoA analysis (Fig. 6). While in 
Exp. A, there was a clear separation between all groups in 
the composition of the microbiota composition, in Exp. B, 
non-inoculated controls and C. jejuni-mono-inoculated 
chickens grouped together as well as the vvIBDV-infected 
and co-inoculated ones. This suggests that at least in Exp. 
B vvIBDV-effects on the microbiota dominate also in co-
inoculated groups, which is interesting and the meaning 
for the host has to be investigated further. We observed 
that C. jejuni-infected birds had a higher abundance of 
Clostridiaceae in the caecal content in both experiments, 
which confirms previous studies [3, 33]. C. jejuni coloni-
zation results in hydrogen consumption, which promotes 
the growth of some Clostridium sp. through increased fer-
mentation, leading to an increased organic acid produc-
tion, which subsequently allows C. jejuni to use organic 
acids as an energy source [34]. Faecalibacterium, a butyrate 
producer, dominates in the caecal microbiota of chick-
ens at approximately 3  weeks of age [35]. High numbers 
of Faecalibacterium may be detrimental for C. jejuni since 
butyrate may inhibit replication of C. jejuni [36]. Different 
colonization rates between C. jejuni mono-inoculated and 
co-inoculated birds might have been due to the different 
abundance of Faecalibacterium in the gut microbiota. In 
Exp. B, a higher abundance of Faecalibacterium (13.95%) 
was correlated with a lower abundance of Campylobacter 
(8.83%) in the C. jejuni mono-inoculated birds compared 
to co-inoculated birds, which showed a lower abundance 
of Faecalibacterium (11.07%) with a higher abundance of 
C. jejuni (10.72%). Further studies on the interaction of the 
gut microbiota and C. jejuni need to be conducted to eluci-
date the exact mechanisms being involved in the control of 
C. jejuni in the gut. This may subsequently help to develop 
better control strategies and ultimately reduce the coloni-
zation rate and therefore the risk for infections of humans 
after chicken meat consumption [37].
The role of T cells in the control of C. jejuni was dem-
onstrated in mice and humans, but little is known about 
T cell responses in chickens. In our study a significant 
up-regulation of T lymphocytes was observed locally in 
the caecum of C. jejuni mono-inoculated and co-inocu-
lated birds compared to control birds. This observation 
coincides with previous studies suggesting that the pres-
ence of these  CD4+ and  CD8+ LP T lymphocytes is due 
to an intraluminal antigenic stimulus [3]. It was suggested 
that activated T cells may play a protective role in the 
host defense against C. jejuni infection [3, 38]. Especially 
regulatory T cells (Tregs) may be import in the regulation 
of inflammatory versus anti-inflammatory conditions 
in the gut [39, 40]. vvIBDV did not affect this C. jejuni-
mediated T cell response in the gut. Co-infected groups 
showed a comparable number of LP T lymphocytes as 
C. jejuni-mono-inoculated ones, which did not correlate 
with the increased number of CFU in these groups sug-
gesting a neglectable role of these cells in the control of 
C. jejuni under our experimental conditions.
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Cytokine expression pattern were either influenced by 
C. jejuni or vvIBDV. Co-inoculations only had an enhanc-
ing effect on IL-8 mRNA expression at 3 days pbi com-
pared to the other groups, but the consequences for the 
pathogenesis are not known. The expression pattern of 
IL-6 is dominated by vvIBDV during the acute phase of 
C. jejuni-colonization, and later on by C. jejuni suggest-
ing that this cytokine may not play a key role in the early 
control of C. jejuni.
Conclusion
Our findings demonstrated a significant influence of 
vvIBDV infection on different immune reactions, micro-
biota composition, and subsequently on the coloniza-
tion pattern C. jejuni. Our data suggests an important 
role of the humoral immunity especially in the clear-
ance of C. jejuni. Further studies should address experi-
mental days beyond 21  days pbi, in order to investigate 
this influence of humoral immunity on C. jejuni further. 
Other immune mechanisms being involved in the control 
of C. jejuni may also be affected by vvIBDV, which may 
explain the enhancement of CFU in co-inoculated birds 
in Exp. A during the early phase after bacterial inocula-
tion. The role of the cell-mediated immunity, especially 
Tregs, is less clear, and has to be investigated further, but 
to address this vvIBDV-infection may not be a suitable 
model.
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